Stockreport

Bristol Myers Squibb Announces Positive Topline Result from Pivotal Phase 3 Trial Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) vs. Chemotherapy in Previously Untreated Malignan...

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Opdivo plus Yervoy prolonged survival compared to chemotherapy at interim analysis in CheckMate -743Malignant pleural mesothelioma is a rare and aggressive cancer with l [Read more]